MDM2 and familial pancreatic carcinoma: The pancreatic cancer Panc-1 (p53-mutant) and AsPC-1 (p53-null) cell lines were used in these studies because both cell lines harbor high expression levels of MDM2 and β-catenin, without wild-type p53.